期刊名称：ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Asia-Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia-Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
Indexed / Abstracted in
Academic Search (EBSCO)
Current Abstracts (EBSCO)
EMBASE/Excerpta Medica (Elsevier)
InfoTrac
Journal Citation Reports/Science Edition (Thomson ISI)
MEDLINE/PubMed (NLM)
OCLC FirstSearch Electronic Collections Online (OCLC)
Science Citation Index Expanded (also known as SciSearch®)
SCOPUS (Elsevier)
Instructions to Authors
The Asia-Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia-Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor or the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted to http://mc.manuscriptcentral.com/apjco. The entire article should be supplied as two files, the covering letter and the manuscript. The covering letter should be uploaded as a file not for review in keeping with the review process. Electronic figures and tables should also be supplied as separate files.
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication. Authors must state if the manuscript has been rejected elsewhere and upload the reviewer comments onto mc.manuscriptcentral.com/apjco
· Please note that Word 2007 is not yet compatible with journal production systems. Unfortunately, the journal cannot accept Microsoft Word 2007 documents until such time as a stable production version is released. Please use Word's 'Save As' option therefore to save your document as an older (.doc) file type.
· Specify any special characters used to represent non-keyboard characters.
· Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for b (Greek beta).
· Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
Graphics must be uploaded as high resolution (at least 300 d.p.i.) files, saved as .eps or .tif. Digital images supplied only as low-resolution files cannot be used.
Covering letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter.
The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified.
Authors must declare any financial support or relationships that may pose conflict of interest.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be provided with the covering letter.
Pre-submission English-language editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at http://authorservices.wiley.com/bauthor/english_language.asp. Japanese authors can also find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
Author material archive policy
Authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Wiley-Blackwell will dispose of all hardcopy and electronic material two months after publication.
ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Tokyo 2004), available at http://www.wma.net/e/policy/b3.htm
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
COPYRIGHT
Authors publishing in the Journal will be asked to sign a Copyright Transfer Agreement. In signing the form it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the form, and must sign the Form or agree that the corresponding author can sign on their behalf. Articles cannot be published until a signed form has been received. Authors can download the form from http://www.wiley.com/go/ctaaglobal
ONLINE OPEN
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://onlinelibrary.wiley.com/onlineOpenOrder
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors' revised 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication', as presented at http://www.ICMJE.org/.
Spelling. The journal uses US spelling and authors should therefore follow the latest edition of the Merriam-Webster's Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units.
Abbreviations. Abbreviations should be used sparingly. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name of the manufacturer, in parentheses.
PARTS OF THE MANUSCRIPT
The length of an original article (excluding references, tables and appendices) should not exceed 3500 words.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and keywords, (iii) text, (iv) acknowledgments, (v) references, (vi) appendices, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.
Abstract and key words
All original articles must have a brief structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aims, Methods, Results, Conclusion. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
Text
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.
Acknowledgments
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors' industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
References
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting.
EndNote reference styles can be searched for here: http://www.endnote.com/support/enstyles.aspReference
Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated in the style used in Index Medicus.
Authors are responsible for the accuracy of the references.
Journal article
1 Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med 1996; 124: 980-83.
Online journal article not yet published in an issue
2 Nahta R, Estevea FJHER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res 2006 doi:10.1186/bcr1612
Book
3 Ringsven MK, Bond D. Gerontology and Leadership Skills for Nurses, 2nd edn. Delmar Publishers, Albany NY 1996.
Chapter in a book
4 Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. Raven Press, New York 1995; 465-78.
Website
5 Cancer-Pain.org [homepage on the Internet]. Association of Cancer Online Resources, New York c2000-01 [updated 16 May 2002; cited 9 Jul 2002]. Available from: www.cancer-pain.org/.
Appendices
These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer's name should be included below the title.
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate sheet with the legend above. Legends should be concise but comprehensive - the table, legend and footnotes must be understandable without reference to the text. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, , should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (80.5 mm), intermediate (110 mm) or the full text width (168 mm). Magnifications should be indicated using a scale bar on the illustration.
Figure legends. Type figure legends on a separate page. Legends should be concise but comprehensive - the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Letters to the Editor
Word limit: 500 words
Abstract: No abstract required for this manuscript type
References: Up to 5
Figures/ tables: Up to 1 (multipanel figures allowed)
Letters may be submitted to the Editor on any topic of discussion; substantial clinical observations as well as letters commenting on papers published in recent issues. Letters to the Editor are not subjected to peer-review, but publication is at the discretion of the Editor or Publisher. Submissions may be edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response. Letters that offer perspective on content already published in APJCO can use an arbitrary title, but a Response from authors must cite the title of the first Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
ONLINE GUIDELINES
Please visit our web page for authors at: http://authorservices.wiley.com/bauthor/journal.asp which gives detailed information on the preparation and submission of articles and figures.
Author Services
Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more.
PROOFS
It is essential that corresponding authors supply an email address to which proofs can be emailed. A Portable Document Format (PDF) typeset proof will be sent via email as a final check of the layout, tables and figures. Alterations (other than the essential correction of errors) are unacceptable at PDF stage. Further instructions will be sent with the proof. If the proof is not returned by the appointed date, it may be signed off on by the Editor or held over to the next issue.
OFFPRINTS
A free PDF offprint will be supplied to the corresponding author after publication. A minimum of 50 printed offprints will be provided upon request, at the author's expense. These paper offprints may be ordered online. Please visit http://offprint.cosprinters.com/, fill in the necessary details and ensure that you type information in all of the required fields. If you have queries about offprints please email offprint@cosprinters.com
PUBLICATION FEES
A charge of US$530 for the first three colour figures and US$265 for each extra colour figure thereafter will be charged to the author.
EARLY VIEW
Asia-Pacific Journal of Clinical Oncology is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html
JOURNALS ONLINE
Visit Wiley-Blackwell Author Services pages for submission guidelines and digital graphics standards at http://authorservices.wiley.com/bauthor/journal.asp. Asia-Pacific Journal of Clinical Oncology is also available online at Wiley Online Library.
EDITORIAL OFFICE ADDRESS
Asia-Pacific Journal of Clinical Oncology
Editorial Office
155 Cremorne St,
Richmond, Victoria 3121
Australia
Email: ajco.eo@wiley.com
tel: 61 3 9467 9344; fax: 61 3 9274 3137
Editorial Board
Edited by:
Stephen ACKLAND, Australia
Editors
Alex CHANG, Singapore
Da-Tong CHU, China
Atsushi OHTSU, Japan
Hyun C CHUNG, Korea
Tony MOK, Hong Kong
Consulting Editors
Takeshi SANO, Japan
Associate Editors
Yasuaki ARAI, Japan
Hisao ASAMURA, Japan
Ann-Lii CHENG, Taiwan
Ian D DAVIS, Australia
Michael FRIEDLANDER, Australia
Yasuhiro FUJIWARA, Japan
Simon HSIEH, Taiwan
Barry IACOPETTA, Australia
Guo-Liang JIANG, China
Yasuhiko KIYOZUKA, Japan
Yukio KOBAYASHI, Japan
Brigette MA, Hong Kong
Glen MARSHALL, Australia
Michael MCKAY, Australia
Atsushi OCHIAI, Japan
Nick PAVLAKIS, Australia
Mark ROSENTHAL, Australia
Masahisa SAIKAWA, Japan
Zhi-Xiang SHEN, China
Yun-Tian SUN, China
Benny ZEE, Hong Kong
Editorial Board
Michael BARTON, Australia
Shu-Chang CHEN, China
Lee Soo CHIN, Singapore
Steve CLARKE, Australia
John FORBES, Australia
David GOLDSTEIN, Australia
Dae Seog HEO, South Korea
Ruey-Long HONG, Taiwan
Katsuyuki HOTTA, Japan
Shiu-Feng HUANG, Taiwan
Jay Lu JAIDE, Singapore
Masura KATOH, Japan
Dorothy KEEFE, Australia
Yeul Hong KIM, South Korea
Jin Soo LEE, South Korea
YeXiong LI, China
Bruce MANN, Australia
Motoo NAGANE, Japan
Keunchil PARK, South Korea
Nagahiro SAIJO, Japan
Yasutuna SASAKI, Japan
Mark SMITHERS, Australia
Tomotaka SOBUE, Japan
Qiang SUN, China
Eng-Huat TAN, Singapore
Robert THOMAS, Australia
Sumitra THONGPRASERT, Thailand
Kensei TOBINAI, Japan
Guiyi TU, China
Yohsuke UCHITOMI, Japan
Narin VORAVUD, Thailand
Jun WANG, China
Chih-Hsin YANG, Taiwan
Pan-Chyr YANG, Taiwan
Patsy YATES, Australia
Li ZHANG, China
Editorial Office
Asia Pacific Journal of Clinical Oncology
Editorial Office
Wiley-Blackwell
155 Cremorne Street
Richmond, VIC 3121
Australia
Email: oncology@blackwellpublishingasia.com
tel: 61 3 9467 9344; fax: 61 3 9274 3391
|
